A novel method for simple detection of mutations conferring drug resistance in Mycobacterium leprae, based on a DNA microarray, and its applicability in developing countries
- 1 October 2008
- journal article
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 57 (10), 1213-1219
- https://doi.org/10.1099/jmm.0.2008/002600-0
Abstract
A simple method to detect mutations in the genome of Mycobacterium leprae that confer resistance to key drugs for leprosy was exploited on the basis of a reverse hybridization system. A series of oligonucleotide probes corresponding to each mutation in the folP1, rpoB and gyrA genes for dapsone, rifampicin and ofloxacin resistance, respectively, were selected and fixed on a glass slide as capture probes, to develop a DNA microarray termed the leprosy drug susceptibility-DNA microarray (LDS-DA). Mutations in clinical isolates of M. leprae were successfully identified by the LDS-DA. Feasibility studies were conducted to evaluate the performance of the LDS-DA in two developing countries, Myanmar and the Philippines. The high concordance of the results obtained by this method with the results of nucleotide sequencing strongly supports the applicability of the LDS-DA as a drug susceptibility test in place of sequencing, a time-consuming and costly procedure. This is a rapid and simple method for the simultaneous susceptibility testing of three front-line drugs for leprosy, and solves the problems of previously reported methods.Keywords
This publication has 15 references indexed in Scilit:
- Development and evaluation of a novel multiple-primer PCR amplification refractory mutation system for the rapid detection of mutations conferring rifampicin resistance in codon 425 of the rpoB gene of Mycobacterium lepraeJournal of Medical Microbiology, 2008
- Dihydropteroate Synthase Mutations in the folP1 Gene Predict Dapsone Resistance in Relapsed Cases of LeprosyClinical Infectious Diseases, 2006
- Polymorphism in therpoTgene inMycobacterium lepraeisolates obtained from Latin American countries and its possible correlation with the spread of leprosyFEMS Microbiology Letters, 2005
- Multidrug Resistant Mycobacterium leprae from Patients with LeprosyAntimicrobial Agents and Chemotherapy, 2001
- Simultaneous Detection of Mycobacterium leprae and Its Susceptibility to Dapsone Using DNA Heteroduplex AnalysisJournal of Clinical Microbiology, 2001
- Diaminodiphenylsulfone resistance ofMycobacterium lepraedue to mutations in the dihydropteroate synthase geneFEMS Microbiology Letters, 1999
- Multidrug-resistance to dapsone, rifampicin, and ofloxacin in Mycobacterium lepraeThe Lancet, 1997
- Characterization of rifampin-resistance in pathogenic mycobacteriaAntimicrobial Agents and Chemotherapy, 1994
- Molecular basis of rifampin resistance in Mycobacterium lepraeAntimicrobial Agents and Chemotherapy, 1993
- THE EXPERIMENTAL DISEASE THAT FOLLOWS THE INJECTION OF HUMAN LEPROSY BACILLI INTO FOOT-PADS OF MICEThe Journal of Experimental Medicine, 1960